SCI Pharmtech Inc Cash Flow-to-Debt Ratio
SCI Pharmtech Inc cash flow-to-debt ratio. SCI Pharmtech Inc (4119) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of NT$156.75 Million could theoretically repay 0% of its total liabilities (NT$1.62 Billion) in one year. Check SCI Pharmtech Inc (4119) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SCI Pharmtech Inc (2002–2025)
Cash flow-to-debt ratio of SCI Pharmtech Inc from 2002 to 2025. Historical debt coverage capacity for SCI Pharmtech Inc across 23 annual periods. Check SCI Pharmtech Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
SCI Pharmtech Inc Cash Flow-to-Debt Ratio by Year (2002–2025)
SCI Pharmtech Inc cash flow-to-debt ratio by year from 2002 to 2025. Year-by-year debt coverage analysis for SCI Pharmtech Inc. For the full cash flow conversion analysis, see 4119 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | NT$220.32 Million | NT$1.49 Billion | ▼ -70.4% |
| 2024 | 0.50x | NT$860.52 Million | NT$1.72 Billion | ▲ +268.0% |
| 2023 | 0.14x | NT$215.77 Million | NT$1.59 Billion | ▼ -39.1% |
| 2022 | 0.22x | NT$296.56 Million | NT$1.33 Billion | ▼ -30.9% |
| 2021 | 0.32x | NT$280.28 Million | NT$869.26 Million | ▼ -58.6% |
| 2020 | 0.78x | NT$971.53 Million | NT$1.25 Billion | ▼ -40.3% |
| 2019 | 1.30x | NT$791.60 Million | NT$606.84 Million | ▲ +57.2% |
| 2018 | 0.83x | NT$480.18 Million | NT$578.85 Million | ▲ +7.8% |
| 2017 | 0.77x | NT$281.65 Million | NT$365.88 Million | ▼ -26.5% |
| 2016 | 1.05x | NT$502.11 Million | NT$479.43 Million | ▲ +9.7% |
| 2015 | 0.95x | NT$663.24 Million | NT$695.02 Million | ▲ +164.6% |
| 2014 | 0.36x | NT$358.77 Million | NT$994.64 Million | ▲ +48.9% |
| 2013 | 0.24x | NT$238.57 Million | NT$984.62 Million | ▼ -79.8% |
| 2012 | 1.20x | NT$385.57 Million | NT$321.12 Million | ▲ +85.4% |
| 2011 | 0.65x | NT$249.55 Million | NT$385.26 Million | ▲ +10.5% |
| 2010 | 0.59x | NT$218.96 Million | NT$373.37 Million | ▼ -60.3% |
| 2009 | 1.48x | NT$316.96 Million | NT$214.32 Million | ▲ +14.6% |
| 2008 | 1.29x | NT$245.29 Million | NT$190.16 Million | ▲ +36.1% |
| 2007 | 0.95x | NT$167.53 Million | NT$176.74 Million | ▼ -31.6% |
| 2006 | 1.39x | NT$131.62 Million | NT$94.94 Million | ▲ +133.5% |
| 2004 | 0.59x | NT$76.61 Million | NT$129.03 Million | ▼ -70.4% |
| 2003 | 2.01x | NT$206.86 Million | NT$102.99 Million | ▲ +383.3% |
| 2002 | 0.42x | NT$107.12 Million | NT$257.76 Million | — |